Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy

Anirban Banerjee(University of Maryland, Baltimore), Alexander S. Krupnick(University of Maryland, Baltimore), Dongge Li(Carter Center), Jacqueline S. Slobin(University of Virginia), Zhongcheng Mei(Carter Center), Eric Lazear(Io Therapeutics (United States)), Yizhan Guo(Carter Center), Lea Paragas(University of Virginia), John Westwick(Encore Pharmaceuticals (United States)), Amir Manafi(Arrowhead Regional Medical Center), Craig L. Slingluff(University of Virginia Health System), Lei Shi(University of Wisconsin–Madison), Bayan Mahgoub(University of Virginia), Kang Li(Sun Yat-sen University), Atsushi Hata(Chiba University)
The Journal of Immunology
June 21, 2021
Cited by 10


Related Papers